catechin has been researched along with Altitude Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, H; Cheng, J; Gao, F; He, B; Li, B; Qin, Y; Wan, Y; Zhu, D | 1 |
| Chen, G; Cheng, K; Niu, Y; Wang, X; Zhu, L | 1 |
2 other study(ies) available for catechin and Altitude Hypoxia
| Article | Year |
|---|---|
Epigallocatechin-3-Gallate Ameliorated Iron Accumulation and Apoptosis and Promoted Neuronal Regeneration and Memory/Cognitive Functions in the Hippocampus Induced by Exposure to a Chronic High-Altitude Hypoxia Environment.
Topics: Altitude Sickness; Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Caspase 3; Catechin; Cognition; Hippocampus; Hypoxia; Iron; Maze Learning; Neurons; Oxidative Stress; Rats; Regeneration | 2022 |
(-)-Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling.
Topics: Adenosine Triphosphate; Altitude Sickness; Animals; Anti-Inflammatory Agents; Antioxidants; Aquaporin 4; Brain Edema; Catechin; Hypoxia; Lipopolysaccharides; Mice; Microglia; Neuroprotective Agents; NF-kappa B; Water | 2022 |